Page last updated: 2024-10-29

iopromide and Adrenocortical Carcinoma

iopromide has been researched along with Adrenocortical Carcinoma in 1 studies

iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.

Adrenocortical Carcinoma: A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, SY1
Park, BK1
Park, JJ1
Kim, CK1

Other Studies

1 other study available for iopromide and Adrenocortical Carcinoma

ArticleYear
CT sensitivities for large (≥3 cm) adrenal adenoma and cortical carcinoma.
    Abdominal imaging, 2015, Volume: 40, Issue:2

    Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Contrast Media; Female; Hum

2015